Literature DB >> 35881144

Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling.

Yasaman Motlaghzadeh1, Laila S Tabatabai2, Eric Longo3, Deborah E Sellmeyer4.   

Abstract

Calcinosis cutis is defined as abnormal deposition of calcium salts in the skin and subcutaneous tissues. Dystrophic calcification, the most common form of calcinosis cutis, is associated with autoimmune connective tissue diseases. This condition is associated with severe pain and can affect the patient's quality of life and lead to long-term disability. Treatment is often challenging, and there is a very limited evidence base for potential treatments of calcinosis cutis associated with systemic sclerosis and dermatomyositis. Inkless tattoo is very similar to microneedling, a minimally invasive procedure stimulating the wound-healing cascade contributing to elastin and collagen formation as well as neovascularization. This technique has not been reported as a potential therapeutic option for calcinosis cutis. Here, we present a patient with calcinosis cutis in the setting of dermatomyositis that responded dramatically to inkless tattoo application. Our results support the need for future studies of microneedling in patients with this disorder.
© 2022. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.

Entities:  

Keywords:  Calcinosis cutis; Dermatomyositis; Microneedling; Tattoo

Mesh:

Substances:

Year:  2022        PMID: 35881144     DOI: 10.1007/s00198-022-06501-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  5 in total

1.  An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.

Authors:  Magalys Vitiello; Adriana Abuchar; Néstor Santana; Luis Dehesa; Francisco A Kerdel
Journal:  J Clin Aesthet Dermatol       Date:  2012-07

2.  An Assessment of Microneedling with Topical Growth Factors for Facial Skin Rejuvenation: A Randomized Controlled Trial.

Authors:  Miesha Merati; Christi Woods; Nina Reznik; Lydia Parker
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

3.  Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy.

Authors:  M C Eddy; R Leelawattana; W H McAlister; M P Whyte
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

4.  Regression of cutis calcinosis with diltiazem in adult dermatomyositis.

Authors:  M Abdallah-Lotf; A Grasland; P Vinceneux; M Sigal-Grinberg
Journal:  Eur J Dermatol       Date:  2005 Mar-Apr       Impact factor: 3.328

5.  Therapy of calcinosis universalis complicating adult dermatomyositis.

Authors:  Georgina Terroso; Miguel Bernardes; Abelha Aleixo; Pedro Madureira; Romana Vieira; Alexandra Bernardo; Lúcia Costa
Journal:  Acta Reumatol Port       Date:  2013 Jan-Mar       Impact factor: 1.290

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.